Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × tipifarnib × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

pembrolizumab 19 Cisplatin 9 Carboplatin 8 Bevacizumab 8 Specimen Handling 7 Radiotherapy 7 Human Papillomavirus DNA Tests 7 Colposcopy 7 Paclitaxel 6 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Biopsy 5 lenvatinib 4 Fulvestrant 4 Drug Therapy 4 zimberelimab 3 toripalimab 3 tisotumab vedotin 3 dostarlimab 3 atezolizumab 3 Topotecan 3 Restraint, Physical 3 Radiotherapy, Intensity-Modulated 3 Pemetrexed 3 Nivolumab 3 Mass Screening 3 Cyclophosphamide 3 Brachytherapy 3 spartalizumab 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡